We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Statistical Study Characterizes Patterns of Cancer Chromosome Aneuploidy

By LabMedica International staff writers
Posted on 07 Feb 2012
A large statistical study of cancer genome karyotypes has revealed a pattern linking gain or loss of chromosomes (aneuploidy) in more than 60 different classes of the disease.

Chromosomal aneuploidy is the most common abnormality in cancer. More...
While certain aberrations, most commonly translocations, are known to be strongly associated with specific cancers and contribute to their formation, most aberrations appear to be nonspecific and arbitrary, and do not have a clear effect. The understanding of chromosomal aneuploidy and its role in tumorigenesis is a fundamental open problem in cancer biology.

Loss or gain of chromosomes is usual detrimental or fatal to an organism. Yet, most cancers thrive with bizarre alterations of chromosome number. To understand this phenomenon better, investigators at Tel Aviv University (Israel) systematically studied the characteristics of chromosomal aberrations in over 15,000 cancer karyotypes over 62 cancer classes.

Results published in the June 29, 2011, online edition of the journal Genome Biology revealed a very high co-occurrence rate of chromosome gains with other chromosome gains, and of losses with losses. Gains and losses rarely showed significant co-occurrence. This finding was consistent across cancer classes and was confirmed on an independent comparative genomic hybridization dataset of cancer samples.

“In cancer, there are many cases of extra or missing chromosomes. Yet cancer cells thrive more effectively than other cells,” said senior author Dr. Ron Shamir, professor of computer science at the University of Tel Aviv. “Hopefully future investigation into these chromosomal aberrations will give researchers more clues into why something that is so detrimental to our healthy development is so beneficial to this disease. Cancer is the result of sequences of events, each causing the genome to become more mutated, mixed, and duplicated. Tracking these changes could aid our understanding of the driving forces of cancer's progress.”

Related Links:
Tel Aviv University





Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DROP-AD in-house collection and extraction protocol and testing procedures (Huber, H., Montoliu-Gaya, L., Brum, W.S. et al.; Nat Med (20256); doi.org/10.1038/s41591-025-04080-0)

At-Home Blood Tests Accurately Detect Key Alzheimer's Biomarkers

Diagnosing Alzheimer’s disease typically relies on brain scans or spinal fluid tests, which are invasive, costly, and difficult to access outside specialist clinics. These barriers have limited large-scale... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.